Literature DB >> 2413457

T-cell antigenic sites tend to be amphipathic structures.

C DeLisi, J A Berzofsky.   

Abstract

We propose, on the basis of physical chemical and biological requirements for T-cell activation by antigen, that sites on a protein that can stimulate T lymphocytes will be capable of forming a stable amphipathic structure (i.e., one with separated hydrophobic and hydrophilic surfaces), displaying periodicity in hydrophobic residues. A spectral analysis of the 12 antigenic sites to which the method could be applied indicates that the amphipathic periodicity hypothesis is valid for 10 of them, generally with reliabilities that are well above 98%, with periodicities compatible with an alpha-helical structure. An 11th case manifests a different type of amphipathicity. The analyses require only a knowledge of amino acid sequence. The finding that T-cell antigenic sites show a high correlation with amphipathicity greatly simplifies the search for such sites and is potentially important for vaccine development.

Mesh:

Substances:

Year:  1985        PMID: 2413457      PMCID: PMC391307          DOI: 10.1073/pnas.82.20.7048

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Studies on hypersensitivity. II. Delayed hypersensitivity to denatured proteins in guinea pigs.

Authors:  P G GELL; B BENACERRAF
Journal:  Immunology       Date:  1959-01       Impact factor: 7.397

Review 2.  The antigenic structure of proteins: a reappraisal.

Authors:  D C Benjamin; J A Berzofsky; I J East; F R Gurd; C Hannum; S J Leach; E Margoliash; J G Michael; A Miller; E M Prager
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

3.  Structure of myoglobin refined at 2-0 A resolution. I. Crystallographic refinement of metmyoglobin from sperm whale.

Authors:  T Takano
Journal:  J Mol Biol       Date:  1977-03-05       Impact factor: 5.469

4.  Antigen conformation determines processing requirements for T-cell activation.

Authors:  H Z Streicher; I J Berkower; M Busch; F R Gurd; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

5.  Prediction of protein function from sequence properties. Discriminant analysis of a data base.

Authors:  P Klein; M Kanehisa; C DeLisi
Journal:  Biochim Biophys Acta       Date:  1984-06-28

Review 6.  Amphiphilic secondary structure: design of peptide hormones.

Authors:  E T Kaiser; F J Kézdy
Journal:  Science       Date:  1984-01-20       Impact factor: 47.728

7.  Amphipathic analysis and possible formation of the ion channel in an acetylcholine receptor.

Authors:  J Finer-Moore; R M Stroud
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

8.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

9.  The hydrophobic moment detects periodicity in protein hydrophobicity.

Authors:  D Eisenberg; R M Weiss; T C Terwilliger
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

10.  Influenza virus site recognized by a murine helper T cell specific for H1 strains. Localization to a nine amino acid sequence in the hemagglutinin molecule.

Authors:  C J Hackett; B Dietzschold; W Gerhard; B Ghrist; R Knorr; D Gillessen; F Melchers
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

View more
  123 in total

Review 1.  Rous-Whipple Award Lecture. Chemical features of peptide selection by the class II histocompatibility molecules.

Authors:  E R Unanue
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

2.  Amphipathic variable region heavy chain peptides derived from monoclonal human Wegener's anti-PR3 antibodies stimulate lymphocytes from patients with Wegener's granulomatosis and microscopic polyangiitis.

Authors:  E Peen; C Malone; C Myers; R C Williams; A B Peck; E Csernok; W L Gross; R Staud
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

3.  Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule.

Authors:  Y Yanagi; A Tishon; H Lewicki; B A Cubitt; M B Oldstone
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

Review 4.  Human cartilage proteoglycans as T cell autoantigens.

Authors:  J A Goodacre; J P Pearson
Journal:  Ann Rheum Dis       Date:  1992-09       Impact factor: 19.103

Review 5.  Cellular and humoral antigenic epitopes in HIV and SIV.

Authors:  D F Nixon; K Broliden; G Ogg; P A Broliden
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

Review 6.  Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man.

Authors:  A Tärnvik; M Eriksson; G Sandström; A Sjöstedt
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

Review 7.  Interactions between immunogenic peptides and HLA-DR molecules.

Authors:  J B Rothbard; R Busch
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

8.  Molecular characterization of antigen B2 subunit in two genotypes of Echinococcus granulosus from Indian bubaline isolates, its stage specific expression and serological evaluation.

Authors:  D Pan; A K Bera; S Bandyopadhyay; S Das; T Rana; S K Das; S Bandyopadhyay; B Manna; D Bhattacharya
Journal:  Mol Biol Rep       Date:  2010-09-18       Impact factor: 2.316

9.  Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus.

Authors:  P L Schwimmbeck; T Dyrberg; D B Drachman; M B Oldstone
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

10.  Production and characterization of human proliferative T-cell clones specific for human papillomavirus type 1 E4 protein.

Authors:  J C Steele; T Stankovic; P H Gallimore
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.